Chief Executive Officer Nathan H. Walcker; President and General Manager Lucio Gordan, MD; Gynecological Oncologist Jessica Stine, MD
Fort Myers, Florida, Jan. 12, 2021 (GLOBE NEWSWIRE) — Cancer Specialists and Research Institute in Florida (FCS) Welcomes Board Certified Gynecological Oncologist Jessica Stine, MD. She takes care of patients at the FCS New Port Richey location at 8763 River Crossing Blvd., New Port Richey, FL and in Wesley Chapel at 2391 Oak Myrtle Lane, Wesley Chapel, FL.
After receiving her medical degree from the University of Miami, Dr. Stine completed her residency in obstetrics and gynecology at Jackson Memorial Hospital, where she served as chief administrative resident. She then received a scholarship in gynecologic oncology from the University of North Carolina Hospitals at Chapel Hill.
Before Dr. Stine joined FCS, she established herself as a respected gynecologic oncologist caring for patients in the Tampa Bay area. She served as a proctor and speaker at da Vinci Surgery™ and as an associate professor for the Obstetrics and Gynecology residency at Brandon Regional Hospital. dr. Stine is an advanced robotic surgeon who performs most of the robotic gynecology surgery in the Tampa Bay area. She has a special interest in fertility-sparing approaches and is one of the few doctors trained to perform a radical trachelectomy for young cervical cancer patients who want to preserve their ability to conceive.
dr. Stine has a strong interest in research with a focus on ovarian and endometrial cancer and palliative care. She has presented at numerous professional conferences, including the Society of Gynecologic Oncology, the American Society of Clinical Oncology, and the American Society for Radiation Oncology. Her research has been published in multiple peer-reviewed journals and she is the recipient of multiple awards for research excellence.
“We are proud to expand access to gynecologic cancer care within the New Port Richey community with the addition of this oncology specialty,” said FCS Chief Executive Officer Nathan H. Walcker.
FCS President & Managing Physician dr. Lucio Gordan added: “Dr. Stine has an extensive background in gynecologic oncology and is known for her compassionate care and support for her patients. She has been involved in cancer research, which has led to promising treatments. We are delighted to welcome her to FCS.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national clinical trial entry award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past 5 years, most of the new cancer drugs approved for use in the US have been studied in clinical trials with the participation of Florida Cancer Specialists.* Trained in prestigious medical schools and research institutes such as Duke, Stanford, Harvard, Emory, MD Anderson , and Memorial Sloan Kettering, our doctors are consistently ranked as Top Doctors nationally by US News & World Report.
Florida Cancer Specialists has built a national reputation for excellence reflected in exceptional and compassionate patient care, powered by innovative clinical research, advanced technologies and advanced treatments, including targeted therapies, genome-based treatments and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
CONTACT: Michelle Robey Florida Cancer Specialists (813) 767-9398 Michelle.Robey@FLCancer.com Maryalice Keller Florida Cancer Specialists (585) 314-0172 Maryalice.Keller@FLCancer.com